Related references
Note: Only part of the references are listed.Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains
Yaxing Gui et al.
BRAIN PATHOLOGY (2020)
Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: An exploratory study
Giulia Cisbani et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice
Lifen Liu et al.
BRAIN RESEARCH BULLETIN (2020)
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
Nathalie Bodd Halaas et al.
CEREBRAL CORTEX (2020)
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains
Douglas G. Walker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Association study of serum soluble TREM2 with vascular dementia in Chinese Han population
Qian Wang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice
Farida El Gaamouch et al.
MOLECULAR NEURODEGENERATION (2020)
Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease
Lucia Batzu et al.
NEUROBIOLOGY OF AGING (2020)
Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease
An Li et al.
NEUROBIOLOGY OF AGING (2020)
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge
Alicia A. Nugent et al.
NEURON (2020)
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Luca Kleineidam et al.
ACTA NEUROPATHOLOGICA (2020)
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease
Peter Parbo et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Genetics of Alzheimer's disease: where we are, and where we are going
Celine Bellenguez et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease
Sun Ah Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study
Rola Ismail et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models
Christian Sacher et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease
Giacomo Tondo et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
Lea L. Friker et al.
CELL REPORTS (2020)
Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study
Ling-Zhi Ma et al.
MOLECULAR NEURODEGENERATION (2020)
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
Erik C. B. Johnson et al.
NATURE MEDICINE (2020)
Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies
Brad T. Casali et al.
NEUROBIOLOGY OF DISEASE (2020)
TREM2 ectodomain and its soluble form in Alzheimer's disease
Jiaolong Yang et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease
Simon Dujardin et al.
NATURE MEDICINE (2020)
Investigating Microglia in Health and Disease: Challenges and Opportunities
Veronique E. Miron et al.
TRENDS IN IMMUNOLOGY (2020)
Progranulin Administration Attenuates β-Amyloid Deposition in the Hippocampus of 5xFAD Mice Through Modulating BACE1 Expression and Microglial Phagocytosis
Zhangxin Guan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia
Agnieszka Kulczynska-Przybik et al.
CURRENT ALZHEIMER RESEARCH (2020)
Microglial cathepsin B as a key driver of inflammatory brain diseases and brain aging
Hiroshi Nakanishi
NEURAL REGENERATION RESEARCH (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice
Carola Focke et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume
T. M. Lancaster et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes Introduction
M. Tanaka et al.
DIABETES & METABOLISM (2019)
A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss
Samuel Chiquita et al.
HUMAN MOLECULAR GENETICS (2019)
Glial activation and inflammation along the Alzheimer's disease continuum
Kaja Nordengen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
The protective effects of β-caryophyllene on LPS-induced primary microglia M1/M2 imbalance: A mechanistic evaluation
Vahid Reza Askari et al.
LIFE SCIENCES (2019)
CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum
Boris-Stephan Rauchmann et al.
NEUROBIOLOGY OF AGING (2019)
Neuropathological correlates and genetic architecture of microglial activation in elderly human brain
Daniel Felsky et al.
NATURE COMMUNICATIONS (2019)
In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease
Tatsuhiro Terada et al.
JOURNAL OF NEUROLOGY (2019)
Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels
Xiao-He Hou et al.
NEUROBIOLOGY OF AGING (2019)
CB2 cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP/PS1 mice
Chao Li et al.
NEUROSCIENCE LETTERS (2019)
The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
Carlo Sala Frigerio et al.
CELL REPORTS (2019)
Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies
Jing Zhang et al.
AGING CELL (2019)
LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease
Bradlee L. Heckmann et al.
CELL (2019)
TREM2 function impedes tau seeding in neuritic plaques
Cheryl E. G. Leyns et al.
NATURE NEUROSCIENCE (2019)
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease
Estrella Morenas-Rodriguez et al.
SCIENTIFIC REPORTS (2019)
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Renzo Mancuso et al.
BRAIN (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease
Michael Ewers et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
Simon Sjodin et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Anne-Laure Hemonnot et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor
Kevin Carvalho et al.
BRAIN (2019)
Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease
Dong Kyu Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Yang Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study
Satoru Yamagishi et al.
JOURNAL OF NEUROINFLAMMATION (2019)
NLRP3 inflammasome activation drives tau pathology
Christina Ising et al.
NATURE (2019)
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model
Elizabeth Spangenberg et al.
NATURE COMMUNICATIONS (2019)
Extra-axonal restricted diffusion as an in-vivo marker of reactive microglia
Maxime Taquet et al.
SCIENTIFIC REPORTS (2019)
Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2
Christel Claes et al.
ALZHEIMERS & DEMENTIA (2019)
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Nicholas J. Ashton et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease
Yi-Chen Hsieh et al.
CELL REPORTS (2019)
TET2 Regulates the Neuroinflammatory Response in Microglia
Alejandro Carrillo-Jimenez et al.
CELL REPORTS (2019)
Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study
Tomoyuki Ohara et al.
ANNALS OF NEUROLOGY (2019)
Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study
Diana K. Franco-Bocanegra et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3
Judith Houtman et al.
EMBO JOURNAL (2019)
CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
Dylan J. Finneran et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid- pathology
Marc Suarez-Calvet et al.
MOLECULAR NEURODEGENERATION (2019)
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Samira Parhizkar et al.
NATURE NEUROSCIENCE (2019)
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
Andrew G. Horti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
Ilie-Cosmin Stancu et al.
ACTA NEUROPATHOLOGICA (2019)
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology
Anarmaa Mendsaikhan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease
Jun-ichi Satoh et al.
INTRACTABLE & RARE DISEASES RESEARCH (2019)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease
Francisco R. Lopez-Picon et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
Lin Wang et al.
MOLECULAR NEUROBIOLOGY (2018)
Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease
Kevin M. Budge et al.
MOLECULAR NEUROBIOLOGY (2018)
Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review
K. E. Hopperton et al.
MOLECULAR PSYCHIATRY (2018)
The lysosomal function of progranulin, a guardian against neurodegeneration
Daniel H. Paushter et al.
ACTA NEUROPATHOLOGICA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
Melanie Dani et al.
BRAIN (2018)
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Gemma Navarro et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome
Hua Bai et al.
EXPERIMENTAL CELL RESEARCH (2018)
Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes
Carmen Mecca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
L. M. Bekris et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease
Alicia Lopez et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
Li Zhong et al.
MOLECULAR NEURODEGENERATION (2018)
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease
Justyna Sosna et al.
MOLECULAR NEURODEGENERATION (2018)
Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease
Marjolein Bulk et al.
NEUROBIOLOGY OF AGING (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Bridget Shafit-Zagardo et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
Yonatan A. Cooper et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Altered Processing of β-Amyloid in SH-SY5Y Cells Induced by Model Senescent Microglia
Dafina M. Angelova et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy
Shane M. Bemiller et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Microglia in neurodegeneration
Suzanne Hickman et al.
NATURE NEUROSCIENCE (2018)
Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease
Bahareh Eftekharzadeh et al.
NEURON (2018)
[18F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease
Thomas Keller et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy
Faten A. Sayed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway
Mu Zhang et al.
THERANOSTICS (2018)
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Ione O. C. Woollacott et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease
Juan R. Perea et al.
FRONTIERS IN NEUROSCIENCE (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
Marc Suárez‐Calvet et al.
EMBO Molecular Medicine (2018)
CSF sTREM2 in deliriumrelation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
Kristi Henjum et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo PET-study
Tanja Blume et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
Hong Wang et al.
MOLECULAR NEURODEGENERATION (2018)
Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
Borislav Dejanovic et al.
NEURON (2018)
Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia
Melanie Huettenrauch et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state
Alessandro Villa et al.
THERANOSTICS (2018)
P2Y12 Receptor is Expressed on Human Microglia Under Physiological Conditions Throughout Development and is Sensitive to Neuroinflammatory Diseases
Alexander Mildner et al.
GLIA (2017)
PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis
Hui-Min Xu et al.
MOLECULAR NEUROBIOLOGY (2017)
The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection
Fernanda M. Marim et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease
Jiang Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging
Wanda M. Snow et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Soluble TREM2 induces inflammatory responses and enhances microglial survival
Li Zhong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease
Steven Deleye et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy
Cheryl E. G. Leyns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
Zhiyuan Niu et al.
NATURE COMMUNICATIONS (2017)
Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency
Bret M. Evers et al.
CELL REPORTS (2017)
Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia
Douglas G. Walker et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42
Camilla Lauridsen et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E. O'Bryant et al.
ALZHEIMERS & DEMENTIA (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network
Hideyuki Takahashi et al.
ACTA NEUROPATHOLOGICA (2017)
An early and late peak in microglial activation in Alzheimer's disease trajectory
Zhen Fan et al.
BRAIN (2017)
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Mingqin Zhu et al.
MOLECULAR NEUROBIOLOGY (2016)
Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease
Willem Kamphuis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
Rawaha Ahmad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
The Novel Monoclonal Antibody 9F5 Reveals Expression of a Fragment of GPNMB/Osteoactivin Processed by Furin-like Protease(s) in a Subpopulation of Microglia in Neonatal Rat Brain
Kohichi Kawahara et al.
GLIA (2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave et al.
MOLECULAR NEURODEGENERATION (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suarez-Calvet et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ
S. Strobel et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease
Michael M. Zeineh et al.
NEUROBIOLOGY OF AGING (2015)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
Cecilia E. Hanzel et al.
NEUROBIOLOGY OF AGING (2014)
Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats
Jian-Jun Huang et al.
BRAIN AND BEHAVIOR (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
rs5848 polymorphism and serum progranulin level
Ging-Yuek R. Hsiung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease
Miryam Carecchio et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease
Tae-Suk Kim et al.
NEUROSCIENCE LETTERS (2008)
Caspase-mediated degradation of PPARγ proteins in adipocytes
Fang He et al.
OBESITY (2008)
A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells
A Bouchon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
